Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2014

Cognitive functioning in young children with type 1 diabetes
M. A. Cato
Nemours Children's Clinic

Nelly Mauras
Nemours Children's Clinic

Jodie Ambrosino
Yale University

Aiden Bondurant
Washington University School of Medicine in St. Louis

Amy L. Conrad
Univeristy of Iowa Children's Hospital

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Cato, M. A.; Mauras, Nelly; Ambrosino, Jodie; Bondurant, Aiden; Conrad, Amy L.; Kollman, Craig; Cheng,
Peiyao; Beck, Roy W.; Ruedy, Katrina J.; Aye, Tandy; Reiss, Allan L.; White, Neil H.; and Hershey, Tamara,
,"Cognitive functioning in young children with type 1 diabetes." Journal of the International
Neuropsychological Society. 20,2. 238-247. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/3262

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
M. A. Cato, Nelly Mauras, Jodie Ambrosino, Aiden Bondurant, Amy L. Conrad, Craig Kollman, Peiyao
Cheng, Roy W. Beck, Katrina J. Ruedy, Tandy Aye, Allan L. Reiss, Neil H. White, and Tamara Hershey

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/3262

Journal of the International Neuropsychological Society (2014), 20, 238–247.
Copyright E INS. Published by Cambridge University Press, 2014.
doi:10.1017/S1355617713001434

Cognitive Functioning in Young Children with Type 1
Diabetes

M. Allison Cato,1 Nelly Mauras,2 Jodie Ambrosino,3 Aiden Bondurant,4 Amy L. Conrad,5 Craig Kollman,6
Peiyao Cheng,6 Roy W. Beck,6 Katrina J. Ruedy,6 Tandy Aye,7 Allan L. Reiss,8 Neil H. White,9 AND
Tamara Hershey10 for the Diabetes Research in Children Network (DirecNet)*
1Divsions

of Neurology, Nemours Children’s Clinic, Jacksonville, Florida
of Endocrinology, Nemours Children’s Clinic, Jacksonville, Florida
3Yale Children’s Diabetes Program, Yale University, New Haven, Connecticut
4Department of Psychiatry, Washington University, St. Louis, Missouri
5Division of Pediatric Psychology, University of Iowa Children’s Hospital, Iowa City, Iowa
6Jaeb Center for Health Research, Tampa, Florida
7Department of Pediatric Endocrinology, Stanford University, Stanford, California
8Department of Radiology, Pediatrics, Psychiatry and Behavioral Sciences, Stanford University, Stanford, California
9Department of Pediatrics and Medicine, Washington University, St. Louis, Missouri
10Departments of Psychiatry, Neurology and Radiology, Washington University, St. Louis, Missouri. *A full listing of the members of
the study group is included in the acknowledgements.
2Division

(RECEIVED August 16, 2013; FINAL REVISION December 9, 2013; ACCEPTED December 9, 2013)

Abstract
The aim of this study was to assess cognitive functioning in children with type 1 diabetes (T1D) and examine whether
glycemic history influences cognitive function. Neuropsychological evaluation of 216 children (healthy controls, n 5 72;
T1D, n 5 144) ages 4–10 years across five DirecNet sites. Cognitive domains included IQ, Executive Functions, Learning
and Memory, and Processing Speed. Behavioral, mood, parental IQ data, and T1D glycemic history since diagnosis
were collected. The cohorts did not differ in age, gender or parent IQ. Median T1D duration was 2.5 years and average
onset age was 4 years. After covarying age, gender, and parental IQ, the IQ and the Executive Functions domain scores
trended lower (both p 5 .02, not statistically significant adjusting for multiple comparisons) with T1D relative to controls.
Children with T1D were rated by parents as having more depressive and somatic symptoms (p , .001). Learning
and memory (p 5 .46) and processing speed (p 5 .25) were similar. Trends in the data supported that the degree of
hyperglycemia was associated with Executive Functions, and to a lesser extent, Child IQ and Learning and Memory.
Differences in cognition are subtle in young children with T1D within 2 years of onset. Longitudinal evaluations will
help determine whether these findings change or become more pronounced with time. (JINS, 2014, 20, 238–247)
Keywords: Cognition, Early onset, T1DM, Hyperglycemia, Hypoglycemia, Children

worse outcomes across a variety of cognitive domains, principally IQ (Northam et al., 1998; Rovet, Ehrlich, & Hoppe,
1987), executive functions (Bjorgaas, Gimse, Vik, & Sand,
1997; Flykanaka-Gantenbein, 2004; Lin, Northam, Rankins,
Werther, & Cameron, 2010; Ly, Anderson, McNamara,
Davis, & Jones, 2011), learning and memory (Gaudieri,
Chen, Greer, & Holmes, 2008; Lin et al., 2010), and processing speed (Lin et al., 2010; Northam et al., 2001; Ryan,
Vega, & Drash, 1985).
Many, but not all studies of adults and children with
childhood-onset type 1diabetes (T1D) have documented
an association between severe hypoglycemia (with seizures
or loss of consciousness) and either poorer cognitive outcomes (Blasetti et al., 2011; Hershey, Craft, Bhargava, &

INTRODUCTION
Young children with type 1diabetes are particularly prone
to experiencing extreme fluctuations in glucose levels
at a time when the developing brain is undergoing wide
ranging maturational changes (Giedd & Rapoport, 2010).
White matter proliferation, neuronal pruning, and refining of
neuronal networks are all actively occurring in childhood
(Bullmore & Sporns, 2012). Several studies assessing cognition in youth with early onset diabetes (EOD) have shown
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White, 1997; Hershey, Lillie, Sadler, & White, 2003, 2004;
Hershey et al., 2005; Lin et al., 2010; Naguib, Kulinskaya,
Lomax, & Garralda, 2009; Northam et al., 2001; Perantie
et al., 2008; Rovet & Ehrlich, 1999) or brain changes
(Ferguson et al., 2003; Haumont, Dorchy, & Pelc, 1979;
Hyllienmark, Maltez, Dandenell, Luvigsson, & Brismar,
2005; Musen et al., 2006; Northam et al., 2009; Perantie
et al., 2011, 2007; Perros, Deary, Sellar, Best, & Frier, 1997).
There is preliminary evidence to suggest that this association
can be detected quite early in young children and youth with
recent onset diabetes (Aye et al., 2011). On the other hand,
results from the Diabetes Control and Complications Trial
(DCCT) long-term follow-up study showed no effect of
severe hypoglycemia history on cognitive function in adults
with T1D, even in the youngest age subgroup (ages 13–18 at
study entry), who were carefully followed for an average of
18 years [The Diabetes Control and Complications Trial/
Epidemiology of Diabetes Interventions and Complications
(DCCT/EDIC) Study Research Group, 2007]. However, the
DCCT cohort may not be entirely representative of the
T1D population. For example, approximately 83% of DCCT
participants had no severe hypoglycemic episodes in their
past, and, due to exclusion criteria, no subject had more
than two severe episodes in the 2 years before enrollment or
evidence of hypoglycemia unawareness.
Chronic hyperglycemia exposure may also affect the brain,
targeting both grey and white matter. Compared to hypoglycemia, however, there is less information on the effects
of hyperglycemia on the developing brain. Greater hyperglycemia exposure has been associated with abnormal grey
and white matter volumes (Perantie et al., 2011, 2007),
decrements in processing speed (Jacobson et al., 2011) and
verbal intelligence (Perantie et al., 2008).
This study was designed to investigate cognitive effects of
T1D in young children (4 to ,10 years old) as compared with
healthy controls, and to characterize the influence of intensity
and frequency of fluctuations in glucose levels (glycemic
excursions) on cognitive functioning in children with T1D.
Novel aspects of this study include capture of a young cohort
with relatively recent disease duration, careful control of
possible influencing factors including parental IQ and mood
status, as well as concurrent collection and analysis of neuroimaging data including DTI and whole brain morphometry
using voxel-based morphometry (VBM). The neuroimaging
results are reported in full elsewhere (Barnea-Goraly N et al.,
2013; Marzelli et al., 2013)
Our cohort offers unique insights to the earliest impact of
dysglycemia on cognition. We hypothesized that cognitive
differences would be observed in all key domains: IQ,
executive functions, memory, and processing speed. We
hypothesized further that degree of cognitive differences
would be associated with level of dysglycemia.

RESEARCH DESIGN AND METHODS
This study was conducted across the five clinical centers of
the Diabetes Research in Children Network (DirecNet) after
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review and approval by local Institutional Review Boards
and the NIH-designated Data Safety Monitoring Board
(DSMB). Parents or guardians provided written informed
consent, and children of appropriate age (per local Institutional
Review Board) also provided assent. These data represent
a portion of baseline evaluation conducted as part of a
larger longitudinal study that includes neuroimaging. Children
between 4 and ,10 years of age with T1D diagnosed before
age 8 and healthy control participants were recruited.
Eligibility criteria for the T1D participants included onset of
T1D after 6 months of age and use of daily insulin therapy for
at least 1 month. For all participants exclusion criteria were as
follows: preterm birth before 34 weeks gestation, low birth
weight (less than 2000 grams), intellectual or learning disability (based on parent-report), prior inpatient psychiatric
treatment or any neurologic disease not related to diabetes.
Control participants included siblings and community
volunteers. Recruitment was monitored and suspended as
needed to achieve a balance (within 10%) of T1D participants
and control participants by the following age groups (4–,5,
5–,6, 6–,7, 7–,8, 8–,9, and 9–,10 years) and by
gender. Eligibility criteria for the healthy controls included
HbA1c, 6.0% (42 mmol/mol), fasting blood glucose
(BG),110 mg/dL, and for siblings of T1D participants,
documented negative pancreatic autoantibodies (ICA, antiinsulin, anti-GAD). Target sample sizes after adjusting for
attrition and missing data were 140 participants with T1D and
70 healthy controls to detect an effect size of 0.5 for each
cognitive domain.

Participants
A total of 144 participants with T1D and 72 healthy controls
participated in the study. Average age was 7 years for both
groups (range, 4.0 to ,10 years). The T1D and control
groups had similar gender distributions, parent education,
and income levels (Table 1). The T1D cohort had a median
duration of diabetes of 2.5 years, ranging from 0.1 to 7.9
years. Among children with T1D 16% (n 5 23) had a history
of at least one episode of severe hypoglycemia and 36%
(n 5 51) had a history of diabetic ketoacidosis (DKA), mostly
at the time of diagnosis.

Glycemic Control
For the T1D participants, available HbA1c levels were obtained
from medical records. History of severe hypoglycemia since the
time of diagnosis was obtained from parent report. Severe
hypoglycemia was defined as requiring assistance of another
person to actively administer carbohydrate, glucagon, or other
resuscitative actions due to altered consciousness. T1D participants wore a continuous glucose monitor (CGM) to collect a
minimum of 72 hr of glycemic data with at least 24 hr of
overnight data collection. For those participants who were
using a CGM for routine management of their diabetes, the
CGM data were collected from their own CGM. For those not
using a CGM for management purposes, an iPro2 (Medtronic
MiniMed, Inc., Northridge, CA) or DexCom SEVEN Plus
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Table 1. Demographics by group
T1D participants (N 5 144)

Control participants (N 5 72)

6.96 6 1.68
4.00 to 9.99
66 (46%)

6.92 6 1.79
4.06 to 9.97
34 (47%)

117 (81%)
10 (7%)
6 (4%)
2 (1%)
9 (6%)
72% (58%, 87%)

62 (86%)
4 (6%)
4 (6%)
0
2 (3%)
61% (35%, 82%)

Age (years)
Mean 6 SD
Range
Female
Race/Ethnicity
White
Hispanic or Latino
African American
Asian
More than one race
BMI percentile median (25th, 75th percentile)
Diabetes duration (years)
Median (25th, 75th percentile)
Range
Age at onset (yrs) mean 6 SD
Range
Severe hypoglycemia historya N (%)
HbA1c (%) (mmol/mol) at enrollment
Mean 6 SD
Range
Parent history of diabetesb N (%)
Relative with diabetesc N (%)
Sibling of a type 1 diabetes subject in study N(%)
Parent education leveld N (%)
,12th Grade
12th Grade
Associates
Bachelors
Masters
Professional
Parent income levele N (%)
Less than $25,000
$25,000 to $49,999
$50,000 to $99,999
$100,000 to $199,999
$200,000 or more
Verbal IQf
Mean 6 SD
Range
Performance IQf
Mean 6 SD
Range

2.5 (1.2, 4.4)
0.1 to 7.9
4.1 6 1.9
0.9–8.0
23 (16%)
7.9 6 0.9 (63 6 10)
6.3 to 10.2 (45 to 88)
21 (15%)
NA
NA

NA
NA
NA
5.2 6 0.2 (33 6 2)
4.7 to 5.8 (28 to 40)
9 (13%)
31 (43%)
18 (25%)

1 (,1%)
20 (14%)
23 (16%)
45 (31%)
36 (25%)
19 (13%)
N 5 134
11 (8%)
23 (17%)
51 (38%)
34 (25%)
15 (11%)

1 (1%)
4 (6%)
7 (10%)
24 (33%)
24 (33%)
12 (17%)
N 5 66
2 (3%)
10 (15%)
24 (36%)
22 (33%)
8 (12%)

108 6 14
74 to 150

112 6 12
86 to 147

109 6 15
73 to 143

112 6 15
84 to 148

a

Includes 18 participants with one episode, 3 with two, 1 with three, and 1 with five episodes.
Among 21 T1D participants, 11 reported T1D and 10 reported T2D; among 9 HC participants, 4 reported T1D and 5 reported T2D. Excludes 3 T1D
participants for whom the biological parents’ information was not available.
c
Only HC participants were asked if they had relative with T1D. Eight participants reported T1D siblings who are not in the study, 3 reported parent,
1 reported grandparent and 1 reported first-cousin with T1D.
d
Highest of primary and secondary care givers.
e
Excludes 10 T1D and 6 HC participants who selected ‘do not know’ or ‘do not want to answer.’
f
One HC subject has missing IQ test.
b

(DexCom, Inc., San Diego, CA) was provided to the participant
at no cost. The study devices were blinded, meaning that the
participant did not have access to the CGM results in real time.
The median (interquartile range) of CGM use was 93 (83, 107)
hr during daytime (6 am – 10 pm), and 48 (42, 56) hr during
nighttime.

Neurocognitive Testing
An age-appropriate neurocognitive battery was administered
by trained personnel certified by the DirecNet neurocognitive
core (T. Hershey and A. Cato). Standard neuropsychological
age-specific measures and behavioral questionnaires were
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Table 2. Neurocognitive Test Battery: Domains and Measures
Cognitive domain

Measurea

Test

Batteryb

IQ

scaled scoree
scaled scoree
scaled scoree
scaled scoree
Detectability
Total correct
Total correct
Total correct
Total items recalled
Total items recalled
standard scored

Block design
Similarities
Vocabulary
Matrix reasoning
CPT2
Auditory Attn
Concept Formation
Numbers
Word Listsc
Dot Locationsc
Visual Match I/II
Decision Speed
Scale
Global Executive Composite
Externalizing
Internalizing
Test
Vocabulary
Matrix Reasoning

WPPSI3/WASI

Executive functions

Learning & Memory
Processing Speed
Mood/Behavior
Executive functioning
Externalizing symptoms
Internalizing symptoms
Covariate
Parent IQ

Measure
Raw score
T score
T score
Measure
Scaled scoree
Scaled scoree

Connor’s
NEPSYII
WJIII Cognitive
CMS
CMS
CMS
WJIII Cognitive
WJIII Cognitive
Battery
BRIEF Parent
BASCII PRS
BASCII PRS
Battery
WASI

a
The z score was calculated for each measure using mean and SD from the current study pooling all participants (N 5 214). For domains with more than one
test, the average was taken giving equal weight to each z score.
b
CMS 5 Children’s Memory Scale (Cohen, 1997); CPT 5 Continuous Performance Test (Connors, 1994); NEPSYII 5 Neuropsychological Battery for
Children, Second Edition (Korkman, Kirk, & Kemp, 2007); WJIII Cognitive 5 Woodcock-Johnson Test of Cognitive Abilities, Third Edition (Woodcock,
McGrew, & Mather, 2001); WPPSI3 5 Wechsler Preschool and Primary Scales of Intelligence, Third Edition (Wechsler, 2002); WASI 5 Wechsler Adult
Scale of Intelligence (Wechsler, 1999); BRIEF 5 Behavior Rating Inventory of Executive Functions (Gioia, Isquith, Guy, & Kenworthy, 2000); BASCII
PRS 5 Behavior Assessment System for Children, Second Edition Parent Rating Scales (Reynolds & Kamphaus, 2004).
c
Same version given regardless of age.
d
Age-based standard score from WJIII Cognitive normative update (NU) sample.
e
Age-based scaled score derived from Wechsler normative sample.

used to derive cognitive, mood, and behavioral domains
of interest. Domains assessed in the children included IQ,
Executive Functions, Learning and Memory, Processing
Speed, parent-reported executive functioning, externalizing
behavior, and internalizing mood symptoms (Table 2). The
assignment of tasks to each cognitive domain was based on
clinical experience. A parent/guardian also completed an
abbreviated IQ measure. On an a priori basis, the cognitive
domains were considered primary outcomes; the parentreported measures of mood and behavior were considered
secondary outcomes; and parent IQ was selected as a planned
covariate.
For T1D participants, at the time of neurocognitive testing
BG concentrations needed to be between 70 and 300 mg/dL.
During testing they were monitored for symptoms of hypoglycemia and BG levels were assessed at least twice at
regular, planned intervals, by fingerstick on a home glucose
meter. Insulin or food was given to titrate BG levels as needed. Ketones were evaluated in cases of BG . 300 mg/dL
and if positive, testing was postponed. Testing was also
suspended if BG dropped ,70, and resumed only when
BG again read within 70–300 mg/dL. Test protocols were
double scored at a centralized location (Washington University in St. Louis), and the results were then analyzed at
the DirecNet Coordinating Center (Jaeb Center for Health
Research, Tampa, FL).

Statistical Methods
A Z-score was calculated for each measure using mean and
SD from the current study pooling all participants (N 5 214)
(Manschot et al., 2006; van den Berg et al., 2010). The calculations were based on ranks using van der Waerden scores
to account for some skewness in the distributions. For
domains with more than one measure, the composite Z-score
was taken as an average giving equal weight to each Z-score.
Domain scores were omitted in participants who did not
complete all sub-domain measures. Repeated measures
least squares regression models were used to account for the
possibility that outcomes from siblings may be correlated.
These models compared children with versus without T1D on
each of the domains and subdomain measures adjusting
for age, gender, and parent IQ. The parent-reported child
depression score was used as an additional covariate for
subdomain analyses as presence of depressive symptoms can
have a deleterious effect on cognition (Murrough, Iacoviello,
Neumeister, Charney, & Iosifescu, 2011).
Primary outcome domains were pre-defined as Delayed
Memory, Executive Functions, Processing Speed and IQ.
Secondary outcomes included parent ratings of executive
functioning, externalizing behavior symptoms and internalizing mood symptoms. Upon inspection of the data, a
ceiling effect was observed for the Delayed Memory domain.
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This domain was therefore replaced with the domain of
Learning and Memory using subdomain measures that did
not exhibit any ceiling effect in the results. Because this
was not a pre-specified domain, it is considered a secondary
outcome in this analysis. All p-values presented in this
manuscript are nominal p-values without correction for
multiple comparisons. For the four primary domains, the
Hochberg step up approach (Hochberg, 1988) was used to
adjust the threshold defining statistical significance to
account for multiple comparisons. No formal correction for
multiple comparisons was made for the other secondary
domains. Effect sizes were calculated for individual subdomains based on the estimated difference and standard error
from a regression model adjusting for the factors mentioned
above. Subdomain analyses were considered secondary and
p-values were only calculated for the composite domains to
mitigate the problem of multiple comparisons.
Within the T1D cohort, additional exploratory analyses
were performed using variables specific to diabetes to characterize the influence of glycemic excursions on cognitive
functioning. Hyperglycemia exposure was estimated by
creating a hyperglycemic index from all available HbA1c
measurements, calculating the incremental area under the
curve (AUC) above an HbA1c level of 6.0% (42 mmol/mol)
using the trapezoid rule. The median (interquartile range) for
total number of HbA1c measurements was 11 (6, 18) overall
and 4 (4, 6) measurements per year. CGM indices (mean
glucose, % readings in target range, % readings in hypoglycemic range, coefficient of variation) were calculated giving
equal weight to each of the 24 hr of the day (Diabetes
Research in Children Network Study Group, 2007). Other
diabetes-specific variables included age of onset, duration of
diabetes, and presence or absence of severe hypoglycemia
history. Spearman partial correlations were conducted
between these variables and each of the cognitive domains,
adjusting for age, gender and parent IQ. No formal correction
was made for the large number of statistical comparisons
arising from combinations of each of these factors with the

cognitive data. All p-values above .01 were considered not
statistically significant.

RESULTS
Primary Outcomes
Covarying for age, gender, and parent IQ, there were trends
for children with T1D to score lower than age-matched
controls in the domains of IQ and Executive Functions (both
p 5 .02, not statistically significant adjusting for multiple
comparisons). There was no significant difference between
groups for Processing Speed (p 5 .25, Table 3).

Secondary Outcomes
Learning and memory (p 5 .46) did not differ between the
groups. Parents reported more internalizing problems in
children with T1D (p , .001). Level of externalizing problems (p 5 .73), parent-reported executive functioning problems (p 5 .26) did not differ between the groups.

Sub-domain Analyses
Within the internalizing domain, parents of children with
T1D reported higher levels on sub-domains of depression,
somatization, and anxiety (Figure 1). Subsequent sub-domain
analyses included level of parent-reported child depression as
an additional covariate to ensure that changes in cognitive
function were not impacted by degree of depressive symptoms. Within the executive functions domain, additionally
covarying for depression, all sub-domain measures but one
(CMS Numbers) differed between the groups. In children
with T1D, scores trended lower on measures of visual
sustained attention (effect size 5 0.34), auditory sustained
attention (effect size 5 0.31) and novel concept formation
(effect size 5 0.30). Scores also trended lower in children
with T1D for both verbal (effect size 5 .38) and performance

Table 3. Comparison of T1D and HC participants on cognition, behavior, and mood

Z- Scores
IQb
Executive Functionsb
Learning and Memoryb
Processing Speedb
BRIEF (Behavior Rating Inventory of Executive Function by
Parent)c
Externalizing (Behavior Assessment by Parent)c
Internalizing (Behavior Assessment by Parent)c
a

N

T1D participants
Mean 6 SD

N

Control participants
Mean 6 SD

p-Valuea

144
135
142
140
140

20.09 6 1.01
20.07 6 0.96
20.01 6 0.97
10.04 6 1.02
10.06 6 0.92

70
70
71
72
68

10.19 6 0.89
10.14 6 1.00
10.03 6 1.01
20.07 6 0.89
20.12 6 1.08

.02a
.02a
.46a
.25a
.26a

144
144

10.03 6 0.96
10.19 6 0.90

70
69

20.07 6 1.01
20.40 6 1.02

.73a
,.001a

Nominal p-value uncorrected for multiple comparisons. Obtained from repeated measures least squares regression models, adjusted for siblings from same
family, age, gender, and parent IQ.
b
Higher scores are better.
c
Higher scores are worse.
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DISCUSSION

IQ
VIQ
PIQ

Executive Functions
CPT Detectability
Auditory Attention
Concept Formation
Numbers

Learning and Memory
Word Lists
Dot Locations

Externalizing
Hyperactivity
Aggression
Conduct Problems

Internalizing
Anxiety
Depression
Somatization

-1.0

-0.5

Type 1 Diabetes scored better

0

+0.5

+1.0

+1.5

Controls scored better

Fig. 1. Estimated effect sizes for cognitive subdomains. The dot
represents the point estimate and the width of the bars represents a
99% confidence interval. The confidence intervals are not otherwise
corrected for multiple comparisons. For the domains of Executive
Functions, IQ, and Learning and Memory, effect sizes to the right of
the vertical line indicate that the control group scored higher. For
Externalizing and Internalizing domains, scores are reversed such
that effect sizes to the right of the vertical line indicate that the
control group had less symptoms.

IQ (effect size 5 .17) as well as verbal (effect size 5 0.24) but
not visual learning and memory (effect size 5 20.001).

Relationship to Glycemic Variables
Within the T1D group, children with a history of DKA and
severe hypoglycemia (DKA & SH, N 5 12) trended as
having lower scores on the IQ measure (p 5 .06) relative to
those with no history of either DKA or SH (Table 4). Trends
were also observed across several indices in the direction
of a deleterious effect of hyperglycemia on IQ, Executive
Functions, and Learning and Memory. Trends included the
hyperglycemic index based on all HbA1c values. Chronic
hyperglycemia indexed by averaged A1c AUC above
6.0% (see methods) was associated with lower Child IQ
(p 5 .05) and Learning and Memory (p 5 .05) domain scores
(Table 5). From the CGM data, T1D cases with a higher
percentage of euglycemia (glucose values between 71
and 180 mg/dL) had higher scores within the Executive
Functions domain (p 5 .01) (Table 6). Trends included that
hyperglycemia was associated with lower scores on the
Executive Functions domain, such that the percentage of time
blood glucose values were above 180 mg/dL was associated
with a lower Executive Functions domain score (p 5 .04).
A final trend was that a higher mean glucose score was
associated with a lower Executive Functions domain score
(p 5 .03).

In this cohort of young children with T1D, trends toward
cognitive differences were observed relative to controls in
the areas of intellectual ability and executive functions (both
p 5 .02) after accounting for parent IQ and level of parentreported depression. These findings are subtle and did not
meet our threshold for statistical significance. The clinical
significance of the findings is uncertain, given the modest
effects. Nonetheless, the findings are in keeping with Aye
et al. (2011). Together, results suggest that cognitive differences may emerge in young children with T1D, even after
relatively short disease duration. Mood differences were
identified in the form of more somatic, depressive, and
anxious symptoms. The mood differences observed in this
young cohort are consistent with extant literature, particularly
during the time around diagnosis (Kovacs, Goldston,
Obrosky, & Bonar, 1997).
One could surmise that we did not find more pronounced
cognitive differences because of the high functioning nature
of our cohort. Baseline IQ findings in the Lin et al. 2010
study, however, were quite similar (Average FSIQ of 108 for
T1D patients and 110 for Controls). That said, it is possible
that cognitive differences might be identified earlier or in
a more pronounced manner in the overall population of
children with type 1 diabetes. An additional possibility is
that our test battery was not sufficiently sensitive to detect
cognitive differences. Tests in wide clinical use were selected
for this protocol. It is possible that use of tasks from the
experimental or cognitive literature (e.g., Hershey’s spatial
delayed memory task) might have yielded more robust findings.
In keeping with the benefits of euglycemia on the developing
brain, T1D youth in this cohort who spent more time in euglycemia performed better on measures of executive functions.
Furthermore, trends in the data suggested a deleterious effect
of hyperglycemia on executive functions. Overall, however,
associations between dysglycemia and cognition did not meet
our threshold for statistical significance. We suspect that the
relationship between cognitive findings and glycemic variables
may become more easily detectable after longer disease duration or in children of an older age. Indeed, in other prospective
studies in which a relationship between glycemic variables and
cognitive functions were reported, the cohorts included older
children. Northam, Anderson, Werther, Warne, and Andrewes
(1999), who studied children at the time of diagnosis and
2 years following disease onset, found significant relationships
between cognitive findings (executive functions of auditory
attention, working memory; and verbal and visual learning and
memory) and both chronic hyperglycemia and recurrent severe
hypoglycemia. It is important to note, however, that these
associations were confined to the older children in the cohort
within the age range of 7 to 14. Likewise, Hershey et al. (2005)
reported a relationship between repeated (>3 episodes) severe
hypoglycemia and spatial memory performance. This combined
cohort consisted of an older age group, ages 6–18. Hershey
and colleagues reported the finding once more in a prospective
study (Perantie et al., 2008) with a cohort ranging in age from
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Table 4. Cognitive outcomes by DKA and severe hypoglycemia

Z- Scores
Non-diabetic
T1D
DKA history
Severe
Moderate
None
p-Valuea
SH history
Seizure/coma
SH without
Seizure/coma
None
p-Valuea
DKA & SH combination
DKA & SH
DKA only
SH only
No DKA/SH
p-Valuea

N

Child IQ
Mean 6 SD

Executive Functions
Mean 6 SD

Learning and Memory
Mean 6 SD

Processing Speed
Mean 6 SD

72
144

10.19 6 0.89
20.09 6 1.01

10.14 6 1.00
20.07 6 0.96

10.03 6 1.01
20.01 6 0.97

20.07 6 0.89
10.04 6 1.02

13
38
91

20.33 6 0.88
20.30 6 0.81
10.06 6 1.07
0.37

20.16 6 0.64
20.25 6 0.84
10.03 6 1.03
0.64

20.31 6 0.73
10.02 6 0.96
10.03 6 0.99
0.47

10.07 6 0.98
20.09 6 1.05
10.10 6 1.03
0.58

12
11

20.49 6 0.92
20.39 6 0.77

20.43 6 0.56
20.19 6 1.01

20.39 6 0.64
10.45 6 0.77

20.42 6 0.86
10.34 6 0.96
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20.03 6 1.03
0.37

20.03 6 0.99
0.24

20.02 6 1.00
0.20

10.05 6 1.04
0.24

12
39
11
80

20.69 6 0.84
20.19 6 0.79
20.17 6 0.78
10.09 6 1.10
0.06

20.26 6 0.83
20.22 6 0.80
20.37 6 0.82
10.09 6 1.05
0.19

10.13 6 0.68
20.11 6 0.97
20.07 6 0.95
10.05 6 1.00
0.80

10.02 6 1.24
20.08 6 0.98
20.10 6 0.66
10.13 6 1.07
0.99

a

p-Value from generalized least square regression models, adjusted for age, gender, and parent IQ, diabetes duration, and incremental AUC above HbA1c
level of 6.0%. Statistical comparison is made between the two most extreme groups (i.e., severe vs. none for DKA history, seizure/coma vs. none for SH
history, DKA & SH vs. No DKA/SH for combination).

in light of trends toward lower verbal IQ and lower verbal
learning and memory functioning in our cohort of young
children with T1D.
It is possible that early central nervous system (CNS) insult
in the form of either severe DKA or SH (with seizure/coma)
could have a delayed impact on cognition such that with time,
the disparity in cognitive scores could grow larger. Likewise,
individuals with less severe CNS insult but with glycemic
dysregulation may show cumulative impact over time or
delayed onset of cognitive deficits. A clinical correlate is
noted in young children treated with cranial radiation therapy
(RT). The cumulative impact of RT and chemotherapy on
young children’s cognitive outcomes emerges over time as

5 to 16 with similar findings of relationship between spatial
memory and hypoglycemia. In these reports, findings were
most pronounced in older children with early diabetes onset
(, 5years) and longer disease duration.
With longer disease duration, a larger variety of cognitive
differences have been reported by Northam and by Hershey,
among others, including the domains of verbal intellectual ability, working memory, and processing speed. After
12 years of disease duration, risk factors of EOD, severe
hypoglycemia and poor metabolic control (hyperglycemia)
were found to be additive, particularly for verbal IQ subtests
and executive functioning tasks (Lin et al., 2010). These previous findings related to verbal IQ are particularly interesting
Table 5. Cognitive outcomes by diabetes history among T1D subjectsa

Averaged A1c AUC above 6.0%
Correlation
p-Value
N
Diabetes duration
Correlation
p-Value
N
Age at onset (yrs)
Correlation
p-Value
N
a

Child IQ

Executive Functions

Learning and Memory

Processing Speed

20.17
.05
140

20.15
.10
131

20.17
.05
138

10.04
.63
136

20.06
.47
140

20.02
.78
131

10.07
.41
138

20.12
.16
136

10.05
.54
140

10.04
.67
131

20.04
.64
138

10.09
.30
136

Results from Spearman partial correlations controlling for age, gender, and parent IQ.
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Table 6. Cognitive outcomes by glycemic indices measured by CGM data among T1D subjectsa

% Glucose in target range (71–180 mg/dL)
Correlation
p-Value
N
% Glucose in hypoglycemia (,70 mg/dL)
Correlation
p-Value
N
% Glucose in hyperglycemia (above 180 mg/dL)
Correlation
p-Value
N
Glucose coefficient of variation (SD/mean)
Correlation
p-Value
N
Mean glucose
Correlation
p-Value
N

Child IQ

Executive Functions

Learning and Memory

Processing Speed

10.13
.13
140

10.22
.01
131

10.01
.91
138

20.09
.32
136

20.09
.29
140

10.04
.62
131

10.08
.34
138

20.04
.66
136

20.09
.31
140

20.19
.04
131

20.02
.79
138

10.10
.27
136

20.12
.16
140

10.02
.86
131

10.05
.60
138

20.05
.59
136

20.10
.26
140

20.20
.03
131

20.05
.58
138

10.07
.45
136

a

Results from Spearman partial correlations controlling for age, gender, and parent IQ.

revealed in the late effects literature (Yeates, Ris, Taylor, &
Pennington, 2010).
One purported mechanism to explain these conclusions is
that damage to white matter development and proliferation
results in neurocognitive deficits. Likewise, CNS insult to
children with EOD may have a delayed, progressive and
cumulative impact on cognition over time. Concurrent baseline neuroimaging analysis performed by our DirecNet study
group with this cohort supports the hypothesis that white
matter disruption has occurred at this early stage in disease
progression. Using DTI, white matter integrity differences
were found such that in our cohort, children with T1D had
reduced axial diffusivity (AD) in multiple widespread brain
regions when compared with controls. Within the T1D group,
earlier onset of diabetes, longer disease duration, and higher
HbA1c values significantly influenced white matter findings
(Barnea-Goraly et al., 2013). In addition, our group used
whole brain structural analysis (VBM) to reveal group differences in this young cohort including decreased gray matter
volume (GMV) in several posterior regions and increased
GMV in regions within the temporal and prefrontal cortices.
Again, dysglycemia was significantly related to the observed
brain structure differences (Marzelli et al., 2013).
In summary, cognitive differences are subtle in young
children with T1D at relatively short disease duration (2.5 years
on average). These results lead us to hypothesize that the
identified trends toward group differences are likely related to
the impact of glycemic variability on the developing brain, and
over time, the effects become more pronounced and thus, more
easily detected. Longitudinal follow up of this cohort will better
characterize any association of these cognitive changes with
dysglycemia.

Important next steps in our cohort of young children are to
determine whether these differences become more pronounced
over time and to determine whether stronger relationships
emerge between observed cognitive differences and glycemic
variables. Furthermore, cognitive testing along with concurrent neuroimaging studies over time will help reveal if
dynamic changes in brain systems, such as perturbations in
white matter proliferation during this time frame, relate to the
observed cognitive findings in children with T1D.
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